Near-complete response to low-dose ceritinib in recurrent infantile inflammatory myofibroblastic tumour

Abhenil Mittal1, Aarushi Gupta2, Sameer Rastogi1, Adarsh Barwad3 and Swati Sharma2

ecancer 15 1213 (2021)

1Department of Medical Oncology, Dr Bhim Rao Ambedkar (BRA) Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi 110029, India

2Department of Radiodiagnosis, ABVIMS and Dr RML Hospital, New Delhi 110001, India

3Department of Pathology, All India Institute of Medical Sciences, New Delhi 110029, India

Keywords: ceritinib, infant, inflammatory myofibroblastic tumour, low dose

Correspondence to: Sameer Rastogi

Published: 13/09/2021
Received: 20/08/2021

Publication costs for this article were supported by ecancer (UK Charity number 1176307).

Copyright: © the authors; licensee ecancermedicalscience. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

The images published in this article were previously used by the authors in the article: Gupta A, Sharma S, and Mittal A et al (2021) Recurrent infantile inflammatory myofibroblastic tumor of mesentery—case report and review of imaging findings Radiol Case Rep 16(3) 504–510 [doi:10.1016/j.radcr.2020.12.027].

The authors have copyright of the images; however, this was not referenced.


Related Articles

Yumna Ahmed, Agha Muhammad Hammad Khan, Urooba Jawwad Rao, Fatima Shaukat, Arhum Jamil, Syed Mohammad Hasan, Sehrish Abrar, Bilal Mazhar Qureshi, Ahmed Nadeem Abbasi
Muibat Haruna, Adetola Olubunmi Daramola, Nicholas Awodele Awolola, Nahla Mustafa Badr, Adekunbiola Aina Fehintola Banjo, Abeer Shaaban
Table of Contents
Table of Contents